Market research
2CN.F Harvest One Cannabis Inc
F EUR Healthcare
Latest close
Latest stored close unavailable
Test a moving-average rule with historical data.
Market facts
- Market cap
- 9M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 1.77
Profile
Instrument facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- Not available
- Market cap
- 9M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 1.77
About
About Harvest One Cannabis Inc
Harvest One Cannabis Inc., through its subsidiaries, develops and provides lifestyle and wellness products to consumers and patients in regulated markets worldwide. It operates through two segments, Medical and Nutraceutical, and Consumer. The Medical and Nutraceutical segment is involved in the processing, manufacturing, and distribution of cannabis-based food supplement products. The Consumer segment engages in the marketing, distribution, and product development of liquid sleep shots and sleep powder packets, as well as pain relief creams. Harvest One Cannabis Inc. is headquartered in Vancouver, Canada.
Research context
Harvest One Cannabis Inc appears in PyInvesting’s Frankfurt Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the 2CN.F discussion.
5 years, 6 months ago
Harvest One Cannabis Inc is currently in a long term downtrend where the price is trading 20.4% below its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.5.
Harvest One Cannabis Inc's total revenue rose by 9.5% to $2M since the same quarter in the previous year.
Its net income has increased by 10.7% to $-14M since the same quarter in the previous year.
Finally, its free cash flow grew by 41.1% to $-4M since the same quarter in the previous year.
Based on the above factors, Harvest One Cannabis Inc gets an overall score of 4/5.